NASDAQ
Qualigen Therapeutics, Inc. (QLGN) has a interest coverage ratio of -13.36x as of Wednesday, July 15, 2026. This represents a 90.02% increase compared to its 12-month average of -133.85x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.